Intervention

Placebo comparator

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 29 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials29
Recruiting0
Common conditions25
Lead sponsors shown15
Advertisement

Clinical trials

29 shown
A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs AloneNCT06862791 · 2025-02-18
COMPLETED
A Study in Participants With Obesity or Overweight With at Least One Weight-related ComorbidityNCT06595238 · 2024-10-01
COMPLETED
Virtual Cardiac Wellness Program Following Hypertensive Disorders of PregnancyNCT04998942 · 2021-08-11
UNKNOWN
Oxytocin Treatment in Neonates and Infants With Prader-Willi SyndromeNCT04283578 · 2020-03-10
COMPLETED
CVN058 Effect on Mismatch Negativity in SchizophrenicsNCT03669250 · 2018-11-09
COMPLETED
Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods)NCT02591901 · 2018-04-06
COMPLETED
Vitamin D3 and the Stress-axis in MSNCT02096133 · 2014-10-13
TERMINATED
Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PDNCT03392961 · 2014-03-27
COMPLETED
GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)NCT01854294 · 2013-08-01
COMPLETED
Cognitive Remediation in SchizophreniaNCT01903707 · 2013-05-01
UNKNOWN
Valacyclovir Augmentation for Cognitive and Functional Remediation in SchizophreniaNCT01794897 · 2013-02-01
COMPLETED
RIBOGENE: Optimisation of Riboflavin Status in Hypertensive Adults With a Genetic Predisposition to Elevated Blood PressureNCT02463513 · 2013-02-01
UNKNOWN
Mesenchymal Cells From Autologous Bone Marrow, Administered Intravenously in Patients Diagnosed With Multiple SclerosisNCT01745783 · 2013-01-01
COMPLETED
A Study to Evaluate Safety and Efficacy of DC-TAB in Multiple SclerosisNCT02442570 · 2012-09-01
COMPLETED
Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the HeartNCT01359618 · 2011-06-01
TERMINATED
A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy SubjectsNCT01297062 · 2011-02-01
COMPLETED
To Evaluate the Effect of AZD3199 on the Electrical Activity in the HeartNCT01222442 · 2010-11-01
COMPLETED
Impact of Muscle Afferent Feedback During Exercise in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT01522729 · 2010-10-01
COMPLETED
The Healing Effect of a Two-Herb Recipe on Foot Ulcer in Chinese Patients With Type 2 DiabetesNCT01389362 · 2009-05-01
COMPLETED
Diabetes Prevention - Immune ToleranceNCT01122446 · 2009-04-01
COMPLETED
Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on DonepezilNCT00829374 · 2009-03-01
COMPLETED
Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA)NCT00717808 · 2008-09-01
WITHDRAWN
Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease PatientsNCT00745914 · 2008-09-01
COMPLETED
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)NCT00698828 · 2008-05-15
COMPLETED
Lurasidone HCl A Phase 3 Study of Patients With Acute SchizophreniaNCT00615433 · 2008-01-01
COMPLETED
Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful Peripheral Diabetic NeuropathyNCT00496457 · 2007-05-01
COMPLETED
Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot UlcersNCT00632008 · 2007-03-01
COMPLETED
Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected PatientsNCT00393120 · 2006-10-01
COMPLETED
Omega-3 Fatty Acids for Treating Adults With Major DepressionNCT00517036 · 2006-07-01
COMPLETED

Common conditions

Schizophrenia4Multiple Sclerosis3Chronic Obstructive Pulmonary Disease2Obesity or Overweight2Alzheimer's Disease1Amyotrophic Lateral Sclerosis1Antibiotic Resistance1Cachexia1Chronic Diabetic Foot Ulcers1Chronic Hypertension in Obstetric Context1Chronic Hypertension With Pre-Eclampsia1Depression1Diabetes1Diabetic Foot Ulcer1Diabetic Neuropathy1Eclampsia1Endstage Renal Disease1Gestational Hypertension1Healthy Male1Healthy Subjects1Herpes Simplex1HIV Infections1Hypertension in Pregnancy1Lung Disease1Neurogenic Bladder1

Mapped diseases appearing in these trials

Shared study participation does not establish that this intervention treats a disease.

schizophrenia4multiple sclerosis3chronic obstructive pulmonary disease2Alzheimer disease1amyotrophic lateral sclerosis1depressive disorder1diabetes mellitus1diabetic neuropathy1eclampsia1lung disorder1obsolete neurogenic bladder1Prader-Willi syndrome1prediabetes syndrome1preeclampsia1psychotic disorder1rheumatoid arthritis1schizoaffective disorder1type 1 diabetes mellitus1type 2 diabetes mellitus1

Trial status mix

COMPLETED23
UNKNOWN3
TERMINATED2
WITHDRAWN1

Phase mix

PHASE212
PHASE17
PHASE36
NA5
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.